Ras regulation and function in lymphocytes

Current Opinion in Immunology

Volumn 12, Issue 3, 2000, Pages 289-294

  Genot, Elisabeth ^a   Cantrell, Doreen A ^b  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GUANOSINE TRIPHOSPHATASE;

B LYMPHOCYTE; ENZYME ACTIVATION; GENE INDUCTION; IMMUNOREGULATION; MAST CELL; REVIEW; T LYMPHOCYTE;

EID: 0034092777     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(00)00089-3     Document Type: Review

References (48)

1. Downward J., Graves J.D., Warne P.H., Rayter S., Cantrell D.A. Stimulation of p21ras upon T-cell activation. Nature. 346:1990;719-723.
2. McCormick F. How receptors turn ras on. Nature. 363:1993;15-16.
3. Izquierdo M., Downward J., Graves J.D., Cantrell D.A. Role of protein kinase C in T-cell antigen receptor regulation of p21ras: evidence that two p21ras regulatory pathways coexist in T cells. Mol Cell Biol. 12:1992;3305-3312.
4. Buday L., Downward J. Epidermal growth factor regulates p21ras through the formation of a complex of receptor, Grb2 adapter protein and Sos nucleotide exchange factor. Cell. 73:1993;611-620.
5. Yamanashi Y., Baltimore D. Identification of the Abl- and rasGAP-associated 62 kDa protein as a docking protein, Dok. Cell. 88:1997;205-211.
6. Carpino N., Wisniewski D., Strife A., Marshak D., Kobayashi R., Stillman B., Clarkson B. p62(dok): a constitutively tyrosine-phosphorylated, GAP-associated protein in chronic myelogenous leukemia progenitor cells. Cell. 88:1997;197-204.
7. Yamanashi Y., Tamura T., Kanamori T., Yamane H., Nariuchi H., Yamamoto T., Baltimore D. Role of the rasGAP-associated docking protein p62 (dok) in negative regulation of B cell receptor-mediated signalling. Genes Dev. 14:2000;11-16.
8. Lockyer P.J., Wennstrom S., Kupzig S., Venkateswarlu K., Downward J., Cullen P.J. Identification of the Ras GTPase-activating protein GAP1 (m) as a phosphatidylinositol-3, 4, 5-triphosphate protein in vivo. Curr Biol. 9:1999;265-268.
9. Cheng A., Saxton T., Sakai R., Kulkarni S., Mbamalu G., Vogel W., Tortorice C., Cardiff R., Cross J., Muller W., Pawson T. Mammalian grb2 regulates multiple steps in embryonic-development and malignant transformation. Cell. 95:1998;793-803. Genetic evidence for a mammalian Grb2-Ras signalling pathway, mediated by SH2/SH3 domain interactions, that has multiple functions in embryogenesis and cancer is provided by this study of mice null for Grb2.
10. Holsinger L.J., Spencer D.M., Austin D.J., Schreiber S.L., Crabtree G.R. Signal transduction in T lymphocytes using a conditional allele of Sos. Proc Natl Acad Sci USA. 92:1995;9810-9814.
11. Reif K., Buday L., Downward J., Cantrell D.A. SH3 domains of the adapter molecule Grb-2 complex with two proteins in T cells: the guanine nucleotide exchange protein SOS and a 75-kDa protein that is a substrate for T cell antigen receptor-activated tyrosine kinases. J Biol Chem. 269:1994;14081-14089.
12. Turner H., Reif K., Rivera J., Cantrell D.A. Regulation of the adapter molecule Grb2 by the FceR1 in the mast cell line RBL2H3. J Biol Chem. 270:1995;9500-9506.
13. Zhang W., Sloan-Lancaster J., Kitchen J., Trible R.P., Samelson L.E. LAT: the ZAP-70 tyrosine kinase substrate that links T cell receptor to cellular activation. Cell. 92:1998;83-92.
14. Cantrell D.A. The real LAT steps forward. Trends Cell Biol. 8:1998;180-182.
15. ••].
16. ••].
17. ••] was the first to report LAT characterisation and revealed how this protein fulfilled all predictions about its central importance for antigen receptor function.
18. Clements J.L., Boerth N.J., Lee J.R., Koretzky G.A. Integration of T cell receptor-dependent signalling pathways by adaptor proteins. Annu Rev Immunol. 17:1999;89-108.
19. Liu S.K., Fang N., Koretsky G.A., McGlade C.J. The hematopoietic-specific adaptor protein Gads functions in T-cell signalling via interactions with the SLP-76 and LAT adaptors. Curr Biol. 9:1999;67-75.
20. Yablonski D., Kuhne M.R., Kadlecek T., Weiss A. Uncoupling of nonreceptor tyrosine kinases from PLC-gamma-1 in an SLP-76-deficient T-cell. Science. 281:1998;413-416.
21. O'Ebinu J., Bottorff D.A., Chan E.Y.W., Stang S.L., Dunn R.J., Stone J.C. RasGRP, a Ras guanyl nucleotide releasing protein with calcium and diacylglycerol-binding motifs. Science. 280:1998;1082-1086.
22. Tognon C.E., Kirk H.E., Passmore L.A., Whitehead I.P., Der C.J., Kay R.J. Regulation of RasGRP via a phorbol ester-responsive C1 domain. Mol Cell Biol. 18:1998;6995-7008.
23. Alberola-Ila J., Forbush K.A., Seger R., Krebs E.G., Perlmutter R.M. Selective requirement for MAP kinase activation in thymocyte differentiation. Nature. 373:1995;620-623.
24. ••].
25. ••] revealed for the first time that this developmental block can be overcome by expression of constitutively active mutants of Ras or the Ras effector Raf-1.
26. Turner H., Cantrell D.A. Distinct Ras effector pathways are involved in FcεR1 regulation of the transcriptional activity of Elk-1 and NFAT in mast cells. J Exp Med. 185:1997;43-57.
27. Boussiotis V.A., Freeman G.J., Berezovskaya A., Barber D.L., Nadler L.M. Maintenance of human T cell anergy: blocking of IL-2 gene transcription by activated Rap1. Science. 278:1997;124-128.
28. Genot E., Cleverley S., Henning S., Cantrell D.A. Multiple p21ras effector pathways regulate nuclear factor of activated T cells. EMBO J. 15:1996;3923-3933.
29. •] explore the role of Ras and its effectors in NFAT regulation in lymphocytes and they show that the ability of Ras to synergise with calcineurin to activate NFAT is not mediated by the MAPKs.
30. White M., Nicolette C., Minden A., Polverino A., Van Aelst L., Karin M., Wigler M. Multiple Ras functions can contribute to mammalian cell transformation. Cell. 80:1995;533-541.
31. Rodriguez-Viciana P., Warne P.H., Khwaji A., Marte B.M., Das P., Waterfield M.D., Ridley A., Downward J. Role of phosphoinositide 3-OH kinase in cell transformation and control of the actin cytoskeleton by Ras. Cell. 89:1997;457-467.
32. Marshall C.J. Ras effectors. Curr Opin Cell Biol. 8:1996;197-204.
33. Marshall C. How do small GTPase signal transduction pathways regulate cell cycle entry? Curr Opin Cell Biol. 11:1999;732-736.
34. Genot E., Reif K., Beach S., Kramer I., Cantrell D.A. p21ras initiates Rac-1 but not phosphatidyl inositol 3 kinase/PKB, mediated signalling pathways in T lymphocytes. Oncogene. 17:1998;1731-1738.
35. Pages G., Guerin S., Gral D., Bonino F., Smith A., Anjuere F., Auberger P., Pouyssegur J. Defective thymocyte maturation in p44 MAP kinase (Erk 1) knockout mice. Science. 286:1999;1374-1377. Generally it is considered that Erk1 and Erk2 have redundant roles. This paper challenges that view by revealing a specific defect in thymocyte selection caused by loss of Erk1.
36. Marklund U., Brattsand G., Shingler V., Gullberg M. Serine 25 of oncoprotein 18 is a major cytosolic target for the mitogen-activated protein kinase. J Biol Chem. 268:1993;15039-15049.
37. Ng J., Cantrell D.A. STAT3 is a target for multiple serine kinases in T cells; integrating interleukin 2 and T cell antigen receptor signals. J Biol Chem. 272:1997;24542-24549.
38. Swan K.A., Alberola-Ila J., Gross J.A., Appleby M.W., Forbush K.A., Thomas J.F., Perlmutter R.M. Involvement of p21ras distinguishes positive and negative selection in thymocytes. EMBO J. 14:1995;276-285.
39. Reif K., Lucas S., Cantrell D. A negative role for phosphatidylinositol 3-kinase in T cell antigen receptor function. Curr Biol. 7:1997;285-293.
40. Urano T., Emkey R., Feig L.A. Ral-GTPases mediate a distinct downstream signalling pathway from Ras that facilitates cellular transformation. EMBO J. 15:1996810-816.
41. Bos J.L. All in the family? New insights and questions regarding interconnectivity of Ras, Rap1 and Ral. EMBO J. 17:1998;6776-6782. Rap1 was considered to function as an antagonist of Ras by trapping Ras effectors in an inactive complex. This review summarises recent data that argue that Rap1 functions in a signalling pathway distinct from Ras rather then existing to antagonise Ras action.
42. Van Weering D.H., De Rooij J., Marte B.M., Downward J., Bos J.L., Burgering B.M. Protein kinase B activation and lamellipodium formation are independent phosphoinositide 3-kinase-mediated events differentially regulated by endogenous Ras. Mol Cell Biol. 18:1998;1802-1811.
43. McLeod S.J., Ingham R.J., Bos J.L., Kurosaki T., Gold M.R. Activation of the rap1 GTPase by the B-cell antigen receptor. J Biol Chem. 273:1998;29218-29223.
44. •].
45. •] present provocative data indicating that activation of different Ras isoforms can have distinct biochemical consequences for the cell.
46. Magee T., Marshall C. New insights into the interactions of Ras with the plasma membrane. Cell. 98:1999;9-12.
47. Janes P.W., Ley S.C., Magee A.I. Aggregation of lipid rafts accompanies signalling via the T cell antigen receptor. J Cell Biol. 147:1999;447-461. This reference is an excellent demonstration that spatial organisation of signalling molecules within specialised membrane microdomains is critical for antigen receptor signalling.
48. Roy S., Luetterforst R., Harding A., Apolloni A., Etheridge M., Stang E., Rolls B., Hancock J., Parton R. Dominant-negative caveolin inhibits H-Ras function by disrupting cholesterol-rich plasma membrane domains. Nat Cell Biol. 1:1999;98-105. This study demonstrates that H-Ras and K-Ras, which are targeted to the plasma membrane by different carboxy-terminal anchors, operate in functionally distinct microdomains of the plasma membrane.